文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

严重ARDS患者接受静脉-静脉ECMO期间单纯疱疹病毒与巨细胞病毒再激活

Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO.
PubMed 文献 · Ann Intensive Care · 2019-12-23
一句话结论严重ARDS接受静脉-静脉ECMO的非免疫抑制患者中,54%出现HSV和/或CMV再激活,再激活与机械通气时间延长独立相关,但因果关联待证实。

该研究纳入5年间123例因严重ARDS接受静脉-静脉ECMO的非免疫抑制患者,67例(54%)在ECMO期间出现HSV和/或CMV再激活(20例病毒共感染,40例单纯HSV,7例单纯CMV)。HSV再激活早于CMV(机械通气后6-15天 vs 19天;ECMO后2-8天 vs 14天,均p<0.01)。单因素分析显示再激活与机械通气、ECMO、ICU及住院时间延长相关,但多因素分析中仅与机械通气时间延长独立相关;HSV再激活还独立与机械通气时间和住院时间延长相关。作者结论为再激活常见且与机械通气延长相关,但与呼吸功能恶化的直接因果关系待证实。

要点

  • 123例非免疫抑制严重ARDS接受静脉-静脉ECMO患者中,67例(54%)出现HSV和/或CMV再激活。
  • HSV再激活早于CMV:机械通气后6-15天 vs 19天,ECMO后2-8天 vs 14天(均p<0.01)。
  • 多因素分析中,病毒再激活仅与机械通气时间延长独立相关,与ECMO、ICU及住院时间无独立关联。
  • HSV再激活独立与机械通气时间和住院时间延长相关;共再激活患者机械通气58.5天、ICU停留51.5天,长于单独HSV或CMV再激活者(p<0.05)。
  • 作者指出HSV/CMV再激活与ECMO下呼吸功能恶化的直接因果关系仍待证实。

适用人群与场景

  • 5年期间纳入的123例非免疫抑制的严重ARDS需静脉-静脉ECMO的患者。

研究设计与关键结果

  • 研究类型为5年期间123例非免疫抑制严重ARDS接受静脉-静脉ECMO患者的观察性研究。
  • 67例(54%)在ECMO期间出现HSV和/或CMV再激活:20例病毒共感染,40例单纯HSV,7例单纯CMV。
  • HSV再激活早于CMV:机械通气开始后6-15天 vs 19天(13-29),p<0.01;ECMO启动后2-8天 vs 14天(10-20),p<0.01。
  • 单因素分析中,再激活组较未再激活组机械通气时间延长(22-52.5天 vs 17.5天(9-28),p<0.01)、ECMO时间延长(15天(10-22.5) vs 9天(5-14),p<0.01)、ICU停留延长(29天(19.5-47.5) vs 16天(9-30),p<0.01)、住院延长(44天(29-63.5) vs 24天(11-43),p<0.01)。
  • 多因素分析中,病毒再激活仅与机械通气时间延长独立相关。
  • 单独分析时,HSV再激活组和CMV再激活组机械通气时间分别为29天(19.5-41)和28天(20.5-37),均长于未再激活组的17.5天(9-28),p<0.05。
  • 共再激活患者机械通气58.5天(38-72.3)、ICU停留51.5天(32.5-69),分别长于单独HSV再激活组的27.5天(17.75-35.5)和单独CMV再激活组的29天(20-30.5),p<0.05。
  • 多因素分析中,HSV再激活独立与机械通气时间和住院时间延长相关。

证据类型、等级与局限

  • 证据类型:5年期间123例患者的观察性研究。
  • 局限:作者指出HSV/CMV再激活与ECMO下呼吸功能恶化的直接因果关系仍待证实。

对床旁实践的改变

  • 在非免疫抑制的严重ARDS接受静脉-静脉ECMO患者中,HSV和/或CMV再激活常见(54%),HSV再激活出现较早(ECMO后2-8天),可能提示需关注病毒再激活与机械通气时间延长的关联。
  • 作者指出再激活与呼吸功能恶化的直接因果关系待证实,原文未据此给出抗病毒治疗或常规筛查的推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Herpesviridae reactivation among non-immunocompromised critically ill patients is associated with impaired prognosis, especially during acute respiratory distress syndrome (ARDS). However, little is known about herpes simplex virus (HSV) and Cytomegalovirus (CMV) reactivation occurring in patients with severe ARDS under veno-venous extracorporeal membrane oxygenation (ECMO). We tried to determine the frequency of Herpesviridae reactivation and its impact on patients' prognosis during ECMO for severe ARDS.

RESULTS: During a 5-year period, 123 non-immunocompromised patients with a severe ARDS requiring a veno-venous ECMO were included. Sixty-seven patients (54%) experienced HSV and/or CMV reactivation during ECMO course (20 viral co-infection, 40 HSV alone, and 7 CMV alone). HSV reactivation occurred earlier than CMV after the beginning of MV [(6-15) vs. 19 (13-29) days; p < 0.01] and after ECMO implementation [(2-8) vs. 14 (10-20) days; p < 0.01]. In univariate analysis, HSV/CMV reactivation was associated with a longer duration of mechanical ventilation [(22-52.5) vs. 17.5 (9-28) days; p < 0.01], a longer duration of ECMO [15 (10-22.5) vs. 9 (5-14) days; p < 0.01], and a prolonged ICU [29 (19.5-47.5) vs. 16 (9-30) days; p < 0.01] and hospital stay [44 (29-63.5) vs. 24 (11-43) days; p < 0.01] as compared to non-reactivated patients. However, in multivariate analysis, viral reactivation remained associated with prolonged MV only. When considered separately, both HSV and CMV reactivation were associated with a longer duration of MV as compared to non-reactivation patients [29 (19.5-41) and 28 (20.5-37), respectively, vs. 17.5 (9-28) days; p < 0.05]. Co-reactivation patients had a longer duration of MV [58.5 (38-72.3); p < 0.05] and ICU stay [51.5 (32.5-69) vs. 27.5 (17.75-35.5) and 29 (20-30.5), respectively] as compared to patients with HSV or CMV reactivation alone. In multivariate analysis, HSV reactivation remained independently associated with a longer duration of MV and hospital length of stay.

CONCLUSIONS: Herpesviridae reactivation is frequent among patients with severe ARDS under veno-venous ECMO and is associated with a longer duration of mechanical ventilation. The direct causative link between HSV and CMV reactivation and respiratory function worsening under ECMO remains to be confirmed.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Hraiech S, Bonnardel E, Guervilly C, et al. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO. Ann Intensive Care. 2019. PMID: 31872319. doi:10.1186/s13613-019-0616-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。